Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1937 1
1940 1
1958 2
1960 5
1962 5
1963 6
1964 3
1965 5
1966 2
1967 1
1968 1
1969 3
1970 7
1971 5
1972 8
1973 5
1974 6
1975 14
1976 10
1977 10
1978 9
1979 8
1980 14
1981 11
1982 18
1983 21
1984 16
1985 12
1986 29
1987 24
1988 20
1989 14
1990 20
1991 33
1992 36
1993 23
1994 24
1995 34
1996 24
1997 34
1998 53
1999 57
2000 62
2001 61
2002 66
2003 88
2004 104
2005 99
2006 150
2007 184
2008 184
2009 199
2010 227
2011 253
2012 334
2013 358
2014 341
2015 385
2016 470
2017 493
2018 515
2019 560
2020 643
2021 725
2022 654
Text availability
Article attribute
Article type
Publication date

Search Results

7,026 results
Results by year
Filters applied: . Clear all
Page 1
Response.
Chen JY, Hsu WT, Liu MA, Yo CH, Su CH, Lee CC. Chen JY, et al. Among authors: su ch. Am J Crit Care. 2022 Jan 1;31(1):8-9. doi: 10.4037/ajcc2022925. Am J Crit Care. 2022. PMID: 34972852 No abstract available.
Target Control of Asynchronous Boolean Networks.
Su C, Pang J. Su C, et al. IEEE/ACM Trans Comput Biol Bioinform. 2021 Dec 9;PP. doi: 10.1109/TCBB.2021.3133608. Online ahead of print. IEEE/ACM Trans Comput Biol Bioinform. 2021. PMID: 34882560
Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open-label, long-term extension study with up to 7.0 years of treatment.
Sandborn WJ, Lawendy N, Danese S, Su C, Loftus EV Jr, Hart A, Dotan I, Damião AOMC, Judd DT, Guo X, Modesto I, Wang W, Panés J. Sandborn WJ, et al. Among authors: su c. Aliment Pharmacol Ther. 2022 Feb;55(4):464-478. doi: 10.1111/apt.16712. Epub 2021 Dec 1. Aliment Pharmacol Ther. 2022. PMID: 34854095 Free PMC article.
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
Koshkin VS, Henderson N, James M, Natesan D, Freeman D, Nizam A, Su CT, Khaki AR, Osterman CK, Glover MJ, Chiang R, Makrakis D, Talukder R, Lemke E, Olsen TA, Jain J, Jang A, Ali A, Jindal T, Chou J, Friedlander TW, Hoimes C, Basu A, Zakharia Y, Barata PC, Bilen MA, Emamekhoo H, Davis NB, Shah SA, Milowsky MI, Gupta S, Campbell MT, Grivas P, Sonpavde GP, Kilari D, Alva AS. Koshkin VS, et al. Among authors: su ct. Cancer. 2022 Mar 15;128(6):1194-1205. doi: 10.1002/cncr.34057. Epub 2021 Dec 9. Cancer. 2022. PMID: 34882781
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
Shi R, Wang X, Wu Y, Xu B, Zhao T, Trapp C, Wang X, Unger K, Zhou C, Lu S, Buchner A, Schulz GB, Cao F, Belka C, Su C, Li M, Shu Y. Shi R, et al. Among authors: su c. Theranostics. 2022 May 16;12(9):4181-4199. doi: 10.7150/thno.73235. eCollection 2022. Theranostics. 2022. PMID: 35673559 Free PMC article.
7,026 results